-
-
-
-
-
-
-
Angelini Pharma to acquire Catalyst Pharmaceuticals for $4.1 billion
-
-
-
-
-
-
-
Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program
-
-
-
-
-
-
-
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
-
Catalyst Pharmaceutical (CPRX) PT Raised to $24 at Truist Securities on Vamorolone opportunity
-
-
-
-
-
-
-
Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 Total Revenues and Provides Full Year 2023 Revenue Guidance
-
-
-
-
-
-
-
Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update
-
1,173,888 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

